Dataset Information
(Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
Ontology highlight
ABSTRACT:
SUBMITTER: Semlitsch T
PROVIDER: S-EPMC8095010 | biostudies-literature | 2020 Nov
REPOSITORIES: biostudies-literature
Publications
(Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
The Cochrane database of systematic reviews 20201109
<h4>Background</h4>Evidence that antihyperglycaemic therapy is beneficial for people with type 2 diabetes mellitus is conflicting. While the United Kingdom Prospective Diabetes Study (UKPDS) found tighter glycaemic control to be positive, other studies, such as the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, found the effects of an intensive therapy to lower blood glucose to near normal levels to be more harmful than beneficial. Study results also showed different effects f ...[more]
